Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: A4HC11
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 138 | 140 | PF00675 | 0.665 |
CLV_NRD_NRD_1 | 19 | 21 | PF00675 | 0.723 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.675 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.780 |
CLV_PCSK_KEX2_1 | 19 | 21 | PF00082 | 0.729 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.664 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.468 |
CLV_Separin_Metazoa | 86 | 90 | PF03568 | 0.352 |
DEG_APCC_DBOX_1 | 36 | 44 | PF00400 | 0.524 |
DOC_PP1_RVXF_1 | 119 | 126 | PF00149 | 0.537 |
DOC_USP7_MATH_1 | 24 | 28 | PF00917 | 0.670 |
DOC_USP7_MATH_1 | 55 | 59 | PF00917 | 0.763 |
DOC_USP7_MATH_1 | 73 | 77 | PF00917 | 0.399 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.658 |
DOC_WW_Pin1_4 | 127 | 132 | PF00397 | 0.482 |
DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.649 |
LIG_14-3-3_CanoR_1 | 118 | 124 | PF00244 | 0.533 |
LIG_14-3-3_CanoR_1 | 80 | 88 | PF00244 | 0.354 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.564 |
LIG_LIR_Gen_1 | 113 | 123 | PF02991 | 0.643 |
LIG_LIR_Nem_3 | 113 | 119 | PF02991 | 0.643 |
LIG_SH2_CRK | 91 | 95 | PF00017 | 0.507 |
LIG_SH3_3 | 18 | 24 | PF00018 | 0.654 |
LIG_SH3_3 | 69 | 75 | PF00018 | 0.667 |
LIG_TRAF2_1 | 83 | 86 | PF00917 | 0.500 |
MOD_CK1_1 | 11 | 17 | PF00069 | 0.558 |
MOD_CK2_1 | 108 | 114 | PF00069 | 0.583 |
MOD_Cter_Amidation | 135 | 138 | PF01082 | 0.668 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.623 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.511 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.499 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.523 |
MOD_GlcNHglycan | 45 | 48 | PF01048 | 0.600 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.723 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.656 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.589 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.513 |
MOD_PIKK_1 | 81 | 87 | PF00454 | 0.350 |
MOD_ProDKin_1 | 127 | 133 | PF00069 | 0.486 |
MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.647 |
TRG_ENDOCYTIC_2 | 91 | 94 | PF00928 | 0.506 |
TRG_ER_diArg_1 | 137 | 139 | PF00400 | 0.544 |
TRG_ER_diArg_1 | 19 | 21 | PF00400 | 0.688 |
TRG_ER_diArg_1 | 28 | 30 | PF00400 | 0.664 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IAG5 | Leishmania donovani | 73% | 99% |
A4HZF2 | Leishmania infantum | 73% | 99% |
E9AVE8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 74% | 99% |
Q4QC31 | Leishmania major | 69% | 100% |